JPH02200683A - Tetrabromocyclopenta(b)benzofuran derivative and production thereof - Google Patents
Tetrabromocyclopenta(b)benzofuran derivative and production thereofInfo
- Publication number
- JPH02200683A JPH02200683A JP1898589A JP1898589A JPH02200683A JP H02200683 A JPH02200683 A JP H02200683A JP 1898589 A JP1898589 A JP 1898589A JP 1898589 A JP1898589 A JP 1898589A JP H02200683 A JPH02200683 A JP H02200683A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- benzofuran
- tetrabromocyclopenta
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001907 coumarones Chemical class 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 abstract description 11
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 239000002904 solvent Substances 0.000 abstract description 6
- 229910052751 metal Inorganic materials 0.000 abstract description 5
- 239000002184 metal Substances 0.000 abstract description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007818 Grignard reagent Substances 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 229910052749 magnesium Inorganic materials 0.000 abstract description 3
- 239000011777 magnesium Substances 0.000 abstract description 3
- 238000005727 Friedel-Crafts reaction Methods 0.000 abstract description 2
- 230000003197 catalytic effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229960004676 antithrombotic agent Drugs 0.000 abstract 1
- 239000003699 antiulcer agent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 229910052794 bromium Inorganic materials 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 8
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 238000007363 ring formation reaction Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- MLGZXFKRYXXISS-UHFFFAOYSA-N 1-bromo-2-[4-(2-bromophenoxy)cyclopent-2-en-1-yl]oxybenzene Chemical compound BrC1=CC=CC=C1OC1C=CC(OC=2C(=CC=CC=2)Br)C1 MLGZXFKRYXXISS-UHFFFAOYSA-N 0.000 description 1
- HYGDHSYCSJKRFX-UHFFFAOYSA-N 1h-cyclopenta[b][1]benzofuran Chemical compound O1C2=CC=CC=C2C2=C1C=CC2 HYGDHSYCSJKRFX-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- FAPDDOBMIUGHIN-UHFFFAOYSA-K antimony trichloride Chemical compound Cl[Sb](Cl)Cl FAPDDOBMIUGHIN-UHFFFAOYSA-K 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007256 debromination reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- FEONEKOZSGPOFN-UHFFFAOYSA-K tribromoiron Chemical compound Br[Fe](Br)Br FEONEKOZSGPOFN-UHFFFAOYSA-K 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Abstract
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、式(I)で示される B「 テトラブロモシクロペンタ〔b〕ベンゾフラン誘導体。[Detailed description of the invention] [Industrial application field] The present invention is represented by formula (I) B" Tetrabromocyclopenta[b]benzofuran derivative.
(2) 式(If)で示される
Br Br
テトラブロモシクロペンタ(b)ベンゾフラン誘導体お
よびその製造法に関する。(2) The present invention relates to a Br Br tetrabromocyclopenta(b) benzofuran derivative represented by formula (If) and a method for producing the same.
[従来の技術]
式(I)テトラブロモシクロペンタ(b)ベンゾフラン
誘導体を脱ブロム化することにより容易に得られる式(
m)の
Br
3a、8b−シス−ジヒドロ−3H−シクロペンタ〔b
〕ベンゾフランをブロモ化することを特徴3a、 8
b−シスージヒドo−3H−5.7−ジプロモシクロペ
ンタ(b)ベンゾフランは医薬品、特に抗血栓剤、抗潰
瘍剤、血圧降下剤として有用な5,6.7−4リノルー
4,8−インターmフェニレンPG12誘導体(■)(
特開昭5636477号公報、特開昭58−12477
8号公報他)の鍵合成中間体で、ある(特開昭57−1
44277号公報他)。[Prior art] Formula (I) tetrabromocyclopenta(b) easily obtained by debrominating a benzofuran derivative (
m) Br 3a,8b-cis-dihydro-3H-cyclopenta[b
] Characteristic 3a, 8 brominating benzofuran
b-cissu dihydro-3H-5,7-dipromocyclopenta(b)benzofuran is a 5,6,7-4 linoleum-4,8-inter- m-phenylene PG12 derivative (■) (
JP-A-5636477, JP-A-58-12477
8, etc.), and is a key synthesis intermediate of
44277, etc.).
従来、(m)の製造法として、3,5−シスビス(2,
4,6−)リブロモフェノキシ)シクロペンテン(v)
とグリニヤール試薬とを反応させて、ハロゲン金属交換
を行なった後、金属触媒を加えて環化反応を生起させて
いた(特開昭57144277号公報)。Conventionally, as a method for producing (m), 3,5-cisbis(2,
4,6-)ribromophenoxy)cyclopentene (v)
After reacting with a Grignard reagent to perform halogen metal exchange, a metal catalyst was added to cause a cyclization reaction (Japanese Patent Laid-Open No. 57144277).
0υ [発明が解決しようとする課題] かかる従来技術による場合、次のような問題点がある。0υ [Problem to be solved by the invention] This conventional technique has the following problems.
(1) (III)は沸点が高いため蒸留精製ができ
ない。また、環化反応の収率がよくないため再結晶精製
が困難であり、(■)の精製にカラムクロマトグラフィ
ーを用いている。従って、(I[[)の精製に多大の時
間を要し、(III)の製造コスト高の原因となる。(1) (III) cannot be purified by distillation due to its high boiling point. In addition, recrystallization purification is difficult because the yield of the cyclization reaction is poor, so column chromatography is used to purify (■). Therefore, it takes a lot of time to purify (I[[), which causes an increase in the manufacturing cost of (III).
(2) 環化反、応の収率がハロゲン金属交換反応に
用いるグリニヤール試薬の当量に大きく依存し、当量の
わずかな違いで収率の低下を招く。また、その最適当量
は、3,5−シス−ビス(2,4゜6−ドリブロモフエ
ノキシ)シクロペンテン(V)の純度によって異なり、
収率の再現性が得られないことがある。(2) The yield of the cyclization reaction and the reaction largely depend on the equivalent weight of the Grignard reagent used in the halogen metal exchange reaction, and a slight difference in the equivalent weight causes a decrease in the yield. In addition, the optimum equivalent amount varies depending on the purity of 3,5-cis-bis(2,4゜6-dribromophenoxy)cyclopentene (V),
Yields may not be reproducible.
[課題を解決するための手段]
本発明者らは、かかる従来技術の欠点を克服した(II
I)の工業的製法について鋭意検討した結果、式(II
)で示される
3a、8b−シス−ジヒドロ−3H−シクロペンタ(b
)ベンゾフランから新規化合物である(4)を経由して
、高収率で容易に、しかも再現性よく得る方法を見い出
し、本発明に至った。[Means for Solving the Problems] The present inventors have overcome the drawbacks of the prior art (II
As a result of intensive study on the industrial production method of formula (II),
) 3a,8b-cis-dihydro-3H-cyclopenta(b
) We have discovered a method for obtaining the new compound (4) from benzofuran easily and in high yield with good reproducibility, leading to the present invention.
すなわち本発明は、式(I)で示されるテトラブロモシ
クロペンタ(b)ベンゾフラン誘導体およびその製造法
である。That is, the present invention is a tetrabromocyclopenta(b) benzofuran derivative represented by formula (I) and a method for producing the same.
本発明化合物(I)は、次式の(IA)および(IB)
を含む。The compound (I) of the present invention is represented by (IA) and (IB) of the following formula:
including.
Br Br Br
、Br(IA) (rB)本
発明は、具体的には通常以下の如き条件下に行なう。Br Br Br
, Br(IA) (rB) Specifically, the present invention is usually carried out under the following conditions.
まず本発明の原料である(Il、)は次の方法により容
易に得ることができる。すなわち、特開昭57−144
233の反応条件に従って合成できる(VI)を溶媒に
溶かして、乾燥した金属マグネシウムに加えることによ
りジグリニャール試薬を発生させる。その後、触媒量の
金属試薬を加え、環化させて(II)を得る。環化反応
は、高収率で再現性よく進行し、しかも(Il、)は蒸
留が可能であるため単離精製が容易である。First, (Il,), which is a raw material of the present invention, can be easily obtained by the following method. That is, JP-A-57-144
(VI), which can be synthesized according to the reaction conditions of No. 233, is dissolved in a solvent and added to dry magnesium metal to generate a digrignard reagent. Thereafter, a catalytic amount of metal reagent is added and cyclization is performed to obtain (II). The cyclization reaction proceeds with high yield and good reproducibility, and since (Il,) can be distilled, it is easy to isolate and purify.
(VI)
(fi)
本発明化合物(I)は、(II)を溶媒に溶かして臭素
を加えることにより製造することができる。(VI) (fi) Compound (I) of the present invention can be produced by dissolving (II) in a solvent and adding bromine.
用いる溶媒としては、ジクロロメタン、クロロホルム、
四塩化炭素等の塩素系溶媒や二硫化炭素、酢酸、シクロ
ヘキサンが通常用いられるが、なかでもジクロロメタン
、クロロホルムが好ましい。The solvent used is dichloromethane, chloroform,
Chlorinated solvents such as carbon tetrachloride, carbon disulfide, acetic acid, and cyclohexane are commonly used, and dichloromethane and chloroform are particularly preferred.
臭素の当量はフリーデルクラフッ触媒を用いるか否かに
よって異なる。すなわち、触媒を用いない場合には、臭
素の当量としては3〜10当量が用いられるが、なかで
も4〜6当量が好ましい。触媒を用いる場合には、臭素
の当量としては3〜6当量が用いられるが、なかでも3
〜3.2当量が好ましい。フリーゾルタラフッ触媒とし
ては、鉄、塩化第二鉄、臭化第二鉄、塩化アルミニウム
、臭化アルミニウム、塩化亜鉛、塩化アンチモン(m)
等が通常用いられるが、なかでも鉄、臭化アルミニウム
が好ましい。触媒の当量としては00OO1〜0.5当
量が用いられるが、なかでも0.007〜0.015当
量が好ましい。The equivalent amount of bromine varies depending on whether a Friedel-Craft catalyst is used or not. That is, when a catalyst is not used, the equivalent amount of bromine used is 3 to 10 equivalents, with 4 to 6 equivalents being particularly preferred. When using a catalyst, the equivalent amount of bromine used is 3 to 6 equivalents, especially 3 to 6 equivalents.
~3.2 equivalents are preferred. Free-sol cod fluoride catalysts include iron, ferric chloride, ferric bromide, aluminum chloride, aluminum bromide, zinc chloride, and antimony chloride (m).
etc. are commonly used, and among these, iron and aluminum bromide are preferred. As the equivalent of the catalyst, 00OO1 to 0.5 equivalent is used, and 0.007 to 0.015 equivalent is particularly preferred.
反応温度としては、触媒を用いない場合には20〜10
0℃が用いられ、なかでも20〜60℃が好ましい。触
媒を用いた場合には0〜30°Cが用いられる。The reaction temperature is 20 to 10 when no catalyst is used.
0°C is used, with 20-60°C being preferred. When a catalyst is used, a temperature of 0 to 30°C is used.
反応時間としては、触媒を用いずに行なった場合には1
0分〜1週間が用いられ、なかでも臭素4当量では12
時間〜1日が好ましく、臭素5当量以上では10分〜3
時間が好ましい。触媒を用いた場合には1分〜1週間が
用いられるが、なかでも30分〜1日が好ましい。The reaction time is 1 when carried out without using a catalyst.
0 minutes to 1 week are used, especially for 4 equivalents of bromine, 12
1 hour to 1 day is preferable, and if the amount of bromine is 5 equivalents or more, 10 minutes to 3 hours is preferable.
time is preferable. When a catalyst is used, a time of 1 minute to 1 week is used, and a time of 30 minutes to 1 day is particularly preferred.
その他の反応条件としては、遮光下で反応を行なった方
が好ましいが、これに限るものではない。As for other reaction conditions, it is preferable to carry out the reaction under light shielding, but the conditions are not limited thereto.
(I)の単離方法として、再結晶、シリカゲルカラムク
ロマトグラフィーが用いられるが、反応は定量的に進行
するため、未精製のまま次の反応に供することも可能で
ある。Recrystallization and silica gel column chromatography are used to isolate (I), but since the reaction proceeds quantitatively, it is also possible to use it in the next reaction in an unpurified state.
本発明化合物(I)は、例えばチオ硫酸ナトリウム、硫
化ナトリウムまたは亜鉛等の脱ブロム化剤により、還元
的に脱ブロム化することにより容易に(m)にすること
ができる;
式(III)の化合物から、例えば特開昭57−144
277号公報、特開昭58−124778号公報等に記
載の方法により、医薬品として有用な式(TV)の5.
6.7−)ジノル−4,8−インター
とができる。The compound (I) of the present invention can be easily converted to (m) by reductive debromination with a debrominating agent such as sodium thiosulfate, sodium sulfide or zinc; From compounds, for example, JP-A-57-144
No. 277, JP-A No. 58-124778, etc., the formula (TV) useful as a pharmaceutical is prepared by the method described in 5.
6.7-) dinor-4,8-inter.
[実 施 例コ
以下、本発明を実施例により具体的に説明するが、本発
明はこれらに限定されるものではない。[Examples] Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto.
参考例1
乾燥したマグネシウム1. 3g (53. 5m
mol)に乾燥THF10mlを加えた後、3.5−シ
スビス(2−ブロモフェノキシ)シクロペンテン10g
(24. 4mmol)をTHF70mlに溶かした
ものの一部を加えた。これを加温してグリニヤール反応
を生起させた後、残りのTHF溶液を加えて室温で撹拌
した。次に、乾燥したマグネシウム65、2g (2.
68川o1 )に上記の反応液を加え、更に乾燥THF
0.5ffを加えた後、3,5ビス(2−ブロモフェノ
キシ)シクロペンテン500g (1. 22mol
)をTHF3.5αに溶解させたものを徐々に加えた。Reference example 1 Dry magnesium 1. 3g (53.5m
After adding 10 ml of dry THF to mol), 10 g of 3.5-cisbis(2-bromophenoxy)cyclopentene
(24.4 mmol) dissolved in 70 ml of THF was added. After heating this to cause a Grignard reaction, the remaining THF solution was added and stirred at room temperature. Next, 65.2 g of dried magnesium (2.
Add the above reaction solution to 68 river o1) and add dry THF.
After adding 0.5ff, 500g (1.22mol) of 3,5bis(2-bromophenoxy)cyclopentene
) dissolved in THF3.5α was gradually added.
加え終わった後、50℃で1時間加熱した後水冷した。After the addition was completed, the mixture was heated at 50° C. for 1 hour and then cooled with water.
次にCu11 1、 6g (60. 9+n+n
ol)を加え、40℃で1時間加熱した後水冷した。反
応液に3NNaOH水溶液0.9αを加え、ハイフロス
−パーセルを用いて沢過した。THF2.5Qで濾過し
た固体を洗浄後、P液を濃縮した。濃縮液をシクロヘキ
サン1uで4回抽出し、有機層を2NNaOH水溶液0
.2iで2回、飽和食塩水0.1αで3回洗浄後、無水
硫酸マグネシウムで乾燥した。抽出洗浄時に界面が不明
確な場合には、適宜ハイフロス−パーセルを用いてt濾
過した。そして、硫酸マグネシウムをP別技、P液の有
機層を濃縮した。Next, Cu11 1, 6g (60. 9+n+n
ol) was added, heated at 40°C for 1 hour, and then cooled with water. 0.9α of a 3N NaOH aqueous solution was added to the reaction solution, and the mixture was filtered using Hyfloth Parcel. After washing the filtered solid with THF2.5Q, the P solution was concentrated. The concentrated solution was extracted 4 times with 1 u of cyclohexane, and the organic layer was extracted with 2N NaOH aqueous solution 0.
.. After washing with 2i twice and three times with saturated saline 0.1α, it was dried over anhydrous magnesium sulfate. If the interface was unclear during extraction and washing, t-filtration was performed using Hyfloth Purcel as appropriate. Then, magnesium sulfate was added to P and the organic layer of the P solution was concentrated.
更に3,5−シス−ビス(2−ブロモフェノキシ)シク
ロペンテン816g (1.99mol )を用いて同
様の操作を行ない、2つ合わせて蒸留した。Further, the same operation was carried out using 816 g (1.99 mol) of 3,5-cis-bis(2-bromophenoxy)cyclopentene, and the two were distilled together.
収量 377、0g 収率 73.7%b.p.
77、8〜78.8°C10.1闘HgNMR(
CDC13) δ:
2.80 (IHS dd、J=2. 2.0.5t
(z) 、2.82 (IHS dd、J=5.2.
0、 5Hz) 、4. 35 (IH,d、J=
7゜8Hz) 、5.43 (IH,dddS J
=7゜8.5.2.2. 2Hz) 、5. 71
(2H。Yield: 377.0g Yield: 73.7%b. p.
77, 8-78.8°C 10.1% HgNMR (
CDC13) δ: 2.80 (IHS dd, J=2.2.0.5t
(z), 2.82 (IHS dd, J=5.2.
0, 5Hz), 4. 35 (IH, d, J=
7゜8Hz), 5.43 (IH, dddS J
=7°8.5.2.2. 2Hz), 5. 71
(2H.
s) 、6. 95 (4HS m)IR(液膜法
)νcm”−1:
3060.1602.1582
Mas s :158 (M”)
実施例1
3a、8b−シス−ジヒドロ−3H−シクロペンタ[b
]ベンゾフラン2.0156g (12゜7mg+ol
)をジクロロメタン20m1に溶かし氷冷した後、臭素
3. 9ml (76、2mmol)をゆっくり加えた
。室温で1時間撹拌した後、反応溶液を氷冷した飽和炭
酸水素ナトリウム水溶液100m1に加えた。撹拌しな
がら、チオ硫酸ナトリウム4゜7gを水10m1に溶か
したものを徐々に加えた。s), 6. 95 (4HS m) IR (liquid film method) νcm"-1: 3060.1602.1582 Mass: 158 (M") Example 1 3a,8b-cis-dihydro-3H-cyclopenta[b
]Benzofuran 2.0156g (12゜7mg+ol
) was dissolved in 20 ml of dichloromethane and cooled on ice, and 3. 9 ml (76, 2 mmol) was added slowly. After stirring at room temperature for 1 hour, the reaction solution was added to 100 ml of ice-cooled saturated aqueous sodium hydrogen carbonate solution. While stirring, 4.7 g of sodium thiosulfate dissolved in 10 ml of water was gradually added.
臭素の色が消えたのを確認した後、酢酸エチル50m1
で2回抽出した。有機層を飽和食塩水50m1で洗浄し
、無水硫酸ナトリウムで乾燥した。硫酸ナトリウムをP
別技、濃縮乾固し、減圧乾燥すると褐色粘性液体が得ら
れた。After confirming that the bromine color has disappeared, add 50ml of ethyl acetate.
Extracted twice. The organic layer was washed with 50 ml of saturated brine and dried over anhydrous sodium sulfate. sodium sulfate
Separately, it was concentrated to dryness and dried under reduced pressure to obtain a brown viscous liquid.
収量 6.2725g 収率 103.8%そのう
ち10.1mgをとり、薄層クロマトグラフィー分取に
よりジアステレオマーを分離し、低極性留分として(I
A)6.4■、高極性留分として(IB)3.9mgを
得た。Yield: 6.2725g Yield: 103.8% 10.1mg of it was taken and the diastereomers were separated by thin layer chromatography preparative separation, and as a low polar fraction (I
A) 6.4mg, and (IB) 3.9mg as a highly polar fraction were obtained.
(IA)白色結晶
m、p、 117.0〜119.0°CNMR(C
DC13)δ:
2.69〜2.78 (IH,m) 、3.11〜3.
22 (IHSm) 、4.37〜4゜43 (IH,
m) 、4.43〜4.51(IHSm) 、4.55
〜4.62 (IH。(IA) White crystal m, p, 117.0-119.0° CNMR (C
DC13) δ: 2.69-2.78 (IH, m), 3.11-3.
22 (IHSm), 4.37~4°43 (IH,
m), 4.43-4.51 (IHSm), 4.55
~4.62 (IH.
m) 、5.52〜5.60 (IHSm)、7.32
〜7.41 (IHSm) 、7.49 (IHS
dS J=1.95Hz)I R(KB r) νcm
’:
2970.1452.1258.1187.1135.
1058.992.804.7Mass(EI法、m/
e):472 (M”)高分解能マススペクトル
計算値(CHOB r 4 、M” ) :471.
7309
実測値(M”):471.7323
(IB)白色結晶
m、p、 110.0〜112.0℃NMR(C
DCI 3 )δ:
2.59〜2.70 (IHSm) 、2.97 (I
HSddd、J=15.13.5゜37.3.42Hz
) 、4.35 (IHSt。m), 5.52-5.60 (IHSm), 7.32
~7.41 (IHSm), 7.49 (IHS
dS J=1.95Hz) I R(KB r) νcm
': 2970.1452.1258.1187.1135.
1058.992.804.7Mass (EI method, m/
e): 472 (M”) High-resolution mass spectrum calculation value (CHOB r 4 , M”): 471.
7309 Actual value (M”): 471.7323 (IB) White crystal m, p, 110.0-112.0°C NMR (C
DCI3) δ: 2.59-2.70 (IHSm), 2.97 (I
HSddd, J=15.13.5°37.3.42Hz
), 4.35 (IHSt.
J=7.82Hz) 、4.40 (IHSt。J=7.82Hz), 4.40 (IHSt.
J=5.86Hz) 、4.57〜4.64(IHSm
) 、5.46〜5.53 (IH。J=5.86Hz), 4.57~4.64(IHSm
), 5.46-5.53 (IH.
m) 、7. 34 (IH,s) 、7. 50(
LH,d、、J=1.95Hz)
IR(KB r) νctn−”:
2970.1455.1263.1161.1013.
867.812
Mass(EI法、m/e) : 472 (M” )
高分解能マススペクトル
計算値(CILH80Br 4、M” ) :471
.7309
実測値(M+):471.7349
B【
Br
(IA)
Br Br
(IB)
実施例2
シクロペンタ(b)ベンゾフラン
3a、8b−シス−ジヒドロ−3H−シクロペンタ(b
)ベンゾフラン100g (0,632m。m), 7. 34 (IH,s), 7. 50(
LH, d,, J=1.95Hz) IR(KB r) νctn-”: 2970.1455.1263.1161.1013.
867.812 Mass (EI method, m/e): 472 (M”)
High-resolution mass spectrum calculation value (CILH80Br 4, M”): 471
.. 7309 Actual value (M+): 471.7349 B[ Br (IA) Br Br (IB) Example 2 Cyclopenta(b) Benzofuran 3a,8b-cis-dihydro-3H-cyclopenta(b
) Benzofuran 100g (0,632m.
1)をジクロロメタン02に溶かし、鉄353mg(6
,32mmol)を加えた後水冷した。臭素100m1
(1,96mol )をゆっくり加え、室温で21時
間撹拌した後、反応溶液を氷冷し、炭酸水素ナトリウム
160g (1,90mol )と水IQを加えた。撹
拌しながら、チオ硫酸ナトリウム7゜8g (0,03
141101)を加えた後、水層と有機層を分液した。1) in dichloromethane 02, 353 mg of iron (6
, 32 mmol) and then cooled with water. Bromine 100ml
(1,96 mol) was slowly added and stirred at room temperature for 21 hours, the reaction solution was cooled with ice, and 160 g (1,90 mol) of sodium hydrogen carbonate and water IQ were added. While stirring, add 7°8 g of sodium thiosulfate (0.03
141101), the aqueous layer and organic layer were separated.
水層を酢酸エチル2αで抽出し、有機層を水IQ、飽和
食塩水1uで洗浄した後、無水硫酸マグネシウムで乾燥
した。硫酸マグネシウムをP別技、濃縮乾固し、減圧乾
燥した。The aqueous layer was extracted with ethyl acetate 2α, and the organic layer was washed with water IQ and 1 u of saturated brine, and then dried over anhydrous magnesium sulfate. Magnesium sulfate was concentrated to dryness using P and dried under reduced pressure.
収量 298.7g 収率 99.7%GC純度
93%
参考例2
3a、8b−シス−2,3,3a、8b−テトラヒドロ
−IH−1,2,5,7−テトラブロモシクロペンタ[
b]ベンゾフラン3.00g (6゜31 mmoりを
THFlomlと酢酸10m1の混合溶媒に溶かし、亜
鉛0.8657g (13,2m1IIol)を加えて
1時間室温で撹拌した。反応液を沢過し、P液の溶媒を
留去した。残渣に水20m1.酢酸エチル20m1を加
えて抽出した。更に水層を酢酸エチル20m1で2回抽
出し、有機層を水20m1.飽和食塩水20m1で洗浄
後、無水硫酸マグネシウムで乾燥した。硫酸マグネシウ
ムをP別技、濃縮乾固した。Yield: 298.7g Yield: 99.7% GC purity
93% Reference Example 2 3a,8b-cis-2,3,3a,8b-tetrahydro-IH-1,2,5,7-tetrabromocyclopenta[
b] 3.00 g (6°31 mmol) of benzofuran was dissolved in a mixed solvent of THFloml and acetic acid 10 ml, and 0.8657 g (13.2 ml IIol) of zinc was added and stirred at room temperature for 1 hour. The solvent of the liquid was distilled off. 20 ml of water and 20 ml of ethyl acetate were added to the residue for extraction.The aqueous layer was further extracted twice with 20 ml of ethyl acetate, and the organic layer was washed with 20 ml of water and 20 ml of saturated brine, then anhydrous. It was dried with magnesium sulfate.The magnesium sulfate was separated from P and concentrated to dryness.
収量 1. 95g 収率 97.5%GC純度
96.6%
m、p、 108.0〜109.0℃NMR(C
DC1a )δ:
2.90 (2HSm) 、4.48 (IH。Yield 1. 95g Yield 97.5% GC Purity 96.6% m, p, 108.0-109.0℃ NMR (C
DC1a) δ: 2.90 (2HSm), 4.48 (IH.
m) 、5.60 (IHSm) 、5.80 (2H
Sm) 、7.25 (IHSdS J−2,0Hz)
7.40 (IHS d、J−2,0Hz)I R(K
B r) シcm−’:
3070.2980.2920.1595、1570.
865.830.740.720Mass:
314 (M+) 、316 (M++2) 、3
18 (M” +4)
[発明の効果]
本発明によれば、3a、8b−シス−ジヒドロ−3H−
5,7−ジブロモシクロペンタ〔b〕ベンゾフラン(m
)が、3a、8b−シス−ジヒドロ−3H−シクロペン
タ(b)ベンゾフラン(II)から本発明化合物のテト
ラブロモシクロペンタ[b)ベンゾフラン誘導体(I)
を経由することにより、容易にかつ高収率で、再現性よ
く製造できる。従って、(III)の再結晶による単離
精製が可能となり、工業スケールでの(m)の大量合成
が非常に容易になった。m), 5.60 (IHSm), 5.80 (2H
Sm), 7.25 (IHSdS J-2,0Hz)
7.40 (IHS d, J-2,0Hz) I R (K
B r) cm-': 3070.2980.2920.1595, 1570.
865.830.740.720Mass: 314 (M+), 316 (M++2), 3
18 (M” +4) [Effect of the invention] According to the present invention, 3a,8b-cis-dihydro-3H-
5,7-dibromocyclopenta[b]benzofuran (m
) is 3a,8b-cis-dihydro-3H-cyclopenta (b) benzofuran (II) to the compound of the present invention, tetrabromocyclopenta [b) benzofuran derivative (I)
can be easily produced in high yield and with good reproducibility. Therefore, isolation and purification of (III) by recrystallization became possible, and large-scale synthesis of (m) on an industrial scale became extremely easy.
Claims (2)
〕ベンゾフランをブロモ化することを特徴とする、請求
項(1)記載の式( I )で示されるテトラブロモシク
ロペンタ〔b〕ベンゾフラン誘導体の製造法。(2) Shown by formula (II) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (II) 3a,8b-cis-dihydro-3H-cyclopenta[b
] A method for producing a tetrabromocyclopenta[b]benzofuran derivative represented by formula (I) according to claim (1), which comprises brominating benzofuran.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1898589A JP2782756B2 (en) | 1989-01-27 | 1989-01-27 | Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1898589A JP2782756B2 (en) | 1989-01-27 | 1989-01-27 | Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02200683A true JPH02200683A (en) | 1990-08-08 |
JP2782756B2 JP2782756B2 (en) | 1998-08-06 |
Family
ID=11986884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1898589A Expired - Lifetime JP2782756B2 (en) | 1989-01-27 | 1989-01-27 | Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2782756B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108774207A (en) * | 2018-07-30 | 2018-11-09 | 苏州大学张家港工业技术研究院 | Cyclopenta [c] chromene compounds and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4830501B2 (en) | 2005-02-21 | 2011-12-07 | オムロン株式会社 | Substrate inspection method and apparatus, and inspection logic setting method and apparatus thereof |
-
1989
- 1989-01-27 JP JP1898589A patent/JP2782756B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108774207A (en) * | 2018-07-30 | 2018-11-09 | 苏州大学张家港工业技术研究院 | Cyclopenta [c] chromene compounds and preparation method thereof |
CN108774207B (en) * | 2018-07-30 | 2021-12-17 | 苏州大学张家港工业技术研究院 | Cyclopenta [ c ] chromene compounds and process for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
JP2782756B2 (en) | 1998-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5420310A (en) | Conversion of 15-beta to 15-alpha 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives | |
JPH02200683A (en) | Tetrabromocyclopenta(b)benzofuran derivative and production thereof | |
KR101098201B1 (en) | Fluorinated pentacene derivatives and processes for producing these | |
JP4418048B2 (en) | Process for producing 13-cis-retinoic acid | |
US3354206A (en) | 10, 11-dihydro-5-hydroxy-5-vinyl-5h-dibenzo-[a, d] cycloheptenes | |
JP2782755B2 (en) | Method for producing 3a, 8b-cis-dihydro-3H-5,7-dibromocyclopenta [b] benzofuran | |
JP2000506889A (en) | Method for alkylation and smiles rearrangement of hydroxyaromatic compounds | |
JP2662162B2 (en) | Method for producing 3-alkylpyrrole | |
Wijsman et al. | A stereospecific anionic reduction of gem‐bromohalocyclopropanes by the dimsyl anion | |
KR970001486B1 (en) | Preparation of 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives | |
JPH02200681A (en) | Production of 3a,8b-cis-dihydro-3h-cyclopenta(b)-benzofuran | |
CN116924896A (en) | Synthesis method of naphthalenone compound | |
CN116874359A (en) | Synthesis method of naphthalenone compound | |
JPS63250396A (en) | 3'-azido-3'-deoxythymidine derivative | |
JP3473053B2 (en) | Method for producing acetylene alcohols | |
JPS5857335A (en) | Preparation of 2-(1-indanoyl)acetic acid | |
JP2002060398A (en) | Method for producing torgovdienes and estrones | |
JPH04305548A (en) | Halogeno allyl alcohol derivative | |
JPH0692346B2 (en) | Homophthalic acid derivative and its acid anhydride | |
JPH0535137B2 (en) | ||
JPS6366185A (en) | Production of tilivalline | |
JPS6332778B2 (en) | ||
EP0339815A2 (en) | Process for the preparation of pure cis-cyclopropane carboxylic acids and intermediates therefor | |
JPS61180734A (en) | Cyclopentane derivative | |
JPS60260537A (en) | Preparation of unsaturated carboxylic acid ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080522 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090522 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090522 Year of fee payment: 11 |